Firstly, although bioinformatics analysis provided us with some important insights into FAIM2 in malignancies, and we also validated the tumor suppressor role of FAIM2 in glioma by molecular biology methods, we are still required to validate our results further through biological experiments in vitro or in vivo. The gene discussed is FAIM2; the disease is central nervous system cancer.